Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc12.7 | Diabetes | ECE2007

A propensity-based comparison of haemodialysis and peritoneal dialysis among diabetic patients with end-stage renal disease in the United States

O’Shea LA , Stack AG

Renal transplantation is the optimal treatment strategy for patients with end-stage renal disease (ESRD); few are afforded the opportunity due to limited organ supply. Of the alternatives, peritoneal dialysis (PD) and hemodialysis (HD), it is unclear which confers the greater survival advantage, as prior comparisons have demonstrated conflicting results due to lack of case-mix adjustment, limited follow-up, and failure to consider switches in modality over time.<p class="a...

ea0011p288 | Diabetes, metabolism and cardiovascular | ECE2006

Mortality risks of diabetic patients who reach end stage renal disease (ESRD) in the united states: age and gender differences

Stack AG , O’Shea L

Prior studies have demonstrated that diabetes as a cause of or contributing factor to end stage renal disease (ESRD) has a detrimental impact on survival. What is unclear is whether this effect varies by age and gender.Methods: The objective of this study was to evaluate mortality differences by age and gender among diabetic and non-diabetic ESRD patients in a national cohort. Data on all new ESRD patients (n=451,296) who were initiated on dialysi...

ea0013p195 | Diabetes, metabolism and cardiovascular | SFEBES2007

Apoprotein B and the likelihood of myocardial infarction among persons with reduced kidney function in the U.S. population: the third national health and nutrition examination survey (NHANES III)

O’Shea LA , Nguyen HT , Murthy BVR , Stack AG

Apolipoprotein (Apo)-B is a strong predictor of coronary risk in the general population. Whether it contributes to coronary disease in patients with reduced kidney function is unclear. We examined the prevalence and relationship of Apo-B with physician-diagnosed myocardial infarction among 7,404 adults age >20 years with reduced glomerular filtration rate (GFR) in the U.S. population. GFR was estimated Modification of Diet in Renal Disease Study (MDRD) equation and calibra...

ea0014p514 | (1) | ECE2007

Multicystic dysplastic kidney – a potential accelerant of complications in type I diabetes mellitus

Hillick A , Callaghan B , El Tayeb EH , O’Shea LA , Stack AG

A Multicystic dysplastic kidney (MCDK) is a congenital, renal, cystic transformation usually diagnosed perinatally with 1:1000-4,000 incidence1. The natural history of MCDK is disputed with involution1, enlargement and development of hypertension2, infection and malignant transformation reported in the literature. We describe the incidental detection of An occult MCDK was detected in a 25-year-old chef who presented with a 4 month history of di...

ea0013p110 | Clinical practice/governance and case reports | SFEBES2007

Multicystic dysplastic kidney – a potential accelerant of complications in type I diabetes

Hillick A , O’Shea LA , El Tayeb E , Callaghan PB , Stack AG

A Multicystic Dysplastic Kidney (MCDK) is a congenital, renal, cystic transformation usually diagnosed perinatally with 1:1000 to 4,000 incidence1. The natural history of MCDK is disputed with involution1, enlargement and development of hypertension2, infection and malignant transformation reported in the literature. We describe the case of a 25-year-old chef in whom an occult MCDK was incidentally detected. He presented with a four month histo...